$STI·8-K

Solidion Technology Inc. · Jun 29, 9:23 AM ET

Compare

Solidion Technology Inc. 8-K

Research Summary

AI-generated summary

Updated

Solidion Technology Sets 2026 Annual Meeting for Sept. 15; Proxy Deadlines

What Happened

  • Solidion Technology, Inc. announced that, following the closing of a previously announced private placement, its first annual meeting of stockholders after the effectiveness of its Amended and Restated Certificate of Incorporation will be held on September 15, 2026. The record date, time and location will be disclosed in the company’s proxy statement.
  • The company set deadlines for shareholder submissions related to the meeting: proposals for inclusion in proxy materials under SEC Rule 14a-8 must be received by July 9, 2026; notices required under the SEC’s universal proxy Rule 14a-19 for nominees other than the company’s must be postmarked or electronically transmitted by July 17, 2026.

Key Details

  • Annual Meeting date: September 15, 2026.
  • Rule 14a-8 (proxy inclusion) deadline: July 9, 2026 (timely receipt required).
  • Rule 14a-19 (universal proxy/nominee notice) deadline: July 17, 2026.
  • Submission address: Chief Financial Officer, c/o Solidion Technology, Inc., 13355 Noel Road, Suite 1100, Dallas, TX 75240.
  • Item 5.08 (shareholder director nominations) was noted “to the extent applicable”; proxy statement will include full meeting details.

Why It Matters

  • These dates set the timetable for shareholders who want to submit proposals or nominate directors for inclusion in or consideration at Solidion’s 2026 Annual Meeting. Missing the July deadlines generally means proposals or nominations will be treated as untimely and likely excluded from proxy materials or not considered at the meeting.
  • For investors, the filing signals when proxy materials will be issued and when any contested director elections or shareholder initiatives would need to be launched; no financial results or other material corporate actions were reported in this 8-K.

Loading document...